Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,561,486
-
Share change
-
+1,558,353
-
Total reported value
-
$12,546,742
-
Price per share
-
$8.03
-
Number of holders
-
29
-
Value change
-
+$12,521,589
-
Number of buys
-
26
-
Number of sells
-
2
Institutional Holders of Passage BIO, Inc. - COM NEW (PASG) as of Q3 2025
As of 30 Sep 2025,
Passage BIO, Inc. - COM NEW (PASG) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,561,486 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Vestal Point Capital, LP, Erste Asset Management GmbH, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.